Your browser doesn't support javascript.
loading
Biological treatment interruption in inflammatory bowel disease: Motivation and predictive factors.
Davis González, María Rocío; Ballester, María Pilar; Romero-González, Eva; Sánchez-Pardo, Ana María; Marti-Aguado, David; Tosca, Joan; Suria, Carles; Antón Ausejo, Rosario; Pascual Moreno, Isabel; Planelles Silvestre, María Dolores; Mínguez Pérez, Miguel; Bosca-Watts, Marta Maia.
Afiliación
  • Davis González MR; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Ballester MP; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, Spain. Electronic address: mapibafe@gmail.com.
  • Romero-González E; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Sánchez-Pardo AM; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Marti-Aguado D; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Tosca J; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Suria C; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Antón Ausejo R; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Pascual Moreno I; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Planelles Silvestre MD; Histocompatibility Laboratory, Transfusion Center of Valencian Community, Valencia, Spain.
  • Mínguez Pérez M; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
  • Bosca-Watts MM; IBD Unit, Digestive Disease Medicine, University of Valencia, University Clinic Hospital of Valencia, Spain.
Gastroenterol Hepatol ; 46(9): 671-681, 2023 Nov.
Article en En, Es | MEDLINE | ID: mdl-36375696
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Enfermedades Inflamatorias del Intestino / Colitis Ulcerosa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2023 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Productos Biológicos / Enfermedades Inflamatorias del Intestino / Colitis Ulcerosa Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En / Es Revista: Gastroenterol Hepatol Año: 2023 Tipo del documento: Article País de afiliación: España